| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.2B | $18.4B | $11.6B | $18.8B | $19.2B | $4.1B | $4.3B | $4.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.2B | $3.3B | $-0.8B | $-2.2B | $1.4B | $0.1B | $0.4B | $0.4B |
| EPS (Basic) | $5.94 | $18.66 | $-4.92 | $-13.02 | $7.50 | $0.74 | $2.18 | $1.89 |
| EPS (Diluted) | $5.83 | $18.41 | $-4.92 | $-13.10 | $7.43 | $0.74 | $2.15 | $1.80 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $417.2B | $390.8B | $372.4B | $335.4B | $387.3B | $365.9B | $334.8B | $298.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $406.3B | $382.6B | $365.5B | $331.3B | $367.0B | $343.2B | $315.1B | $283.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $10.9B | $8.3B | $6.9B | $4.1B | $20.3B | $22.7B | $19.7B | $14.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.2B | $-2.0B | $-2.1B | $4.0B | $0.2B | $0.5B | $-2.7B | $1.9B |
| Investing Cash Flow | $-4.0B | $0.8B | $-3.3B | $-11.6B | $-3.6B | $-9.5B | $-5.5B | $-5.8B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $7.9B | $3.6B | $5.4B | $8.3B | $4.3B | $8.1B | $8.4B | $4.6B |